Phoenix Biotech Acquisition Corp. reported earnings results for the seven months ended December 31, 2021. For the seven months, the company reported net loss was USD 0.315547 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2864 USD | -4.60% | -8.79% | -97.40% |
24/06 | CERo Therapeutics Holdings, Inc.(NasdaqGM:CERO) added to S&P TMI Index | CI |
06/06 | CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236 | CI |
1st Jan change | Capi. | |
---|---|---|
-97.40% | 4.31M | |
+16.49% | 122B | |
+21.73% | 115B | |
+21.05% | 26.64B | |
-21.81% | 19.91B | |
-16.89% | 16.32B | |
-44.74% | 15.52B | |
-18.81% | 15.49B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- CERO Stock
- News CERo Therapeutics Holdings, Inc.
- Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Seven Months Ended December 31, 2021